TY - JOUR
T1 - Purification and some properties of two enzymes from rat liver cytosol that catalyze carbonyl reduction of 6-tert-butyl-2,3-epoxy-5-cyclohexene-1,4- dione, a metabolite of 3-tert-butyl-4-hydroxyanisole
AU - Tajima, Kazuo
AU - Hashizaki, Mari
AU - Yamamoto, Kenji
AU - Narimatsu, Shizuo
AU - Mizutani, Tamio
N1 - Funding Information:
1This work was supported by the Special Fund of Hokuriku University. 2 To whom correspondence should be addressed. Fax: +81-76-229-6230.
PY - 1999/1/15
Y1 - 1999/1/15
N2 - 6-tert-Butyl-2,3-epoxy-5-cyclohexene-1,4-dione (TBE), a metabolite of 3- tert-butyl-4-hydroxyanisole, was converted to 6-tert-butyl-2,3-epoxy-4(R)- hydroxy-5-cyclohexen-1-one ((4R)-TBEH) and 6-tert-butyl-2,3-epoxy-4(S)- hydroxy-5-cyclohexen-1-one ((4S)-TBEH) by TBE-reducing enzymes in rat liver cytosol. Two TBE-reducing enzymes (TBE-R1 and TBE-R2) were purified 18- and 117-fold, respectively, to apparent homogeneity from rat liver cytosol using DEAE-Sephacel, Blue Sepharose CL-6B, hydroxylapatite, and Sephadex G-100 column chromatography. Gel filtration and sodium dodecyl sulfate- polyacrylamide gel electrophoresis indicated that both enzymes were monomeric. The purified TBE-R1 and TBE-R2 had molecular weights of 37 and 35 kDa and isoelectric points of 6.5 and 5.8, respectively. Both enzymes had an optimum pH of about 5.5 with TBE as substrate. TBE-R1 utilized NADH or NADPH equally as cofactor, and the K(m) values of NADH and NADPH for TBE with TBE- R1 were estimated to be 15 and 29 μM, respectively. On the other hand, TBE- R2 specifically utilized NADPH and the K(m) value for TBE was estimated to be 92 μM in the presence of NADPH. Both enzymes reduced aromatic aldehydes, ketones, and quinones at higher rates. In addition, TBE-R2 reduced and oxidized 3-ketosteroids at a higher rate in the presence of NAD(H) and/or NADP(H). Both enzyme activities were inhibited by quercitrin or p- chloromercuribenzoic acid, but little inhibition was observed with phenobarbital or pyrazole. Dicoumarol inhibited significantly TBE-R1 activity but not TBE-R2 activity. In the conversion of TBE to TBEH, TBE-R1 preferentially reduced TBE to (4R)-TBEH, whereas TBE-R2 preferred the reduction of TBE to (4S)-TBEH.
AB - 6-tert-Butyl-2,3-epoxy-5-cyclohexene-1,4-dione (TBE), a metabolite of 3- tert-butyl-4-hydroxyanisole, was converted to 6-tert-butyl-2,3-epoxy-4(R)- hydroxy-5-cyclohexen-1-one ((4R)-TBEH) and 6-tert-butyl-2,3-epoxy-4(S)- hydroxy-5-cyclohexen-1-one ((4S)-TBEH) by TBE-reducing enzymes in rat liver cytosol. Two TBE-reducing enzymes (TBE-R1 and TBE-R2) were purified 18- and 117-fold, respectively, to apparent homogeneity from rat liver cytosol using DEAE-Sephacel, Blue Sepharose CL-6B, hydroxylapatite, and Sephadex G-100 column chromatography. Gel filtration and sodium dodecyl sulfate- polyacrylamide gel electrophoresis indicated that both enzymes were monomeric. The purified TBE-R1 and TBE-R2 had molecular weights of 37 and 35 kDa and isoelectric points of 6.5 and 5.8, respectively. Both enzymes had an optimum pH of about 5.5 with TBE as substrate. TBE-R1 utilized NADH or NADPH equally as cofactor, and the K(m) values of NADH and NADPH for TBE with TBE- R1 were estimated to be 15 and 29 μM, respectively. On the other hand, TBE- R2 specifically utilized NADPH and the K(m) value for TBE was estimated to be 92 μM in the presence of NADPH. Both enzymes reduced aromatic aldehydes, ketones, and quinones at higher rates. In addition, TBE-R2 reduced and oxidized 3-ketosteroids at a higher rate in the presence of NAD(H) and/or NADP(H). Both enzyme activities were inhibited by quercitrin or p- chloromercuribenzoic acid, but little inhibition was observed with phenobarbital or pyrazole. Dicoumarol inhibited significantly TBE-R1 activity but not TBE-R2 activity. In the conversion of TBE to TBEH, TBE-R1 preferentially reduced TBE to (4R)-TBEH, whereas TBE-R2 preferred the reduction of TBE to (4S)-TBEH.
KW - Cytosol
KW - Inhibitors
KW - Metabolism
KW - Purification
KW - Rat liver
KW - Reductases
KW - Stereoselectivity
KW - Steroids
KW - Substrate specificity
UR - http://www.scopus.com/inward/record.url?scp=0033555130&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033555130&partnerID=8YFLogxK
U2 - 10.1006/abbi.1998.0986
DO - 10.1006/abbi.1998.0986
M3 - Article
C2 - 9882448
AN - SCOPUS:0033555130
SN - 0003-9861
VL - 361
SP - 207
EP - 214
JO - Archives of Biochemistry and Biophysics
JF - Archives of Biochemistry and Biophysics
IS - 2
ER -